Which revolutionary biotech product launch involved a direct-to-physician educational campaign centered on 'redefining treatment expectations' and became the fastest drug to reach blockbuster status in 2013?

Product launches in the pharmaceutical and biotechnology industries require unique strategies that balance scientific credibility, regulatory compliance, and market acceptance. This trivia question explores one of the most significant product launches in recent scientific history that changed treatment paradigms and represented a breakthrough in how complex biological products are marketed to healthcare providers and patients.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Sovaldi (sofosbuvir) for Hepatitis C
Keytruda (pembrolizumab) for advanced melanoma
Tecfidera (dimethyl fumarate) for multiple sclerosis
Kalydeco (ivacaftor) for cystic fibrosis